Sweden Office +46 (0)8 790 50 01 | UK Office: +44 (0)20 8996 5148 | US Office: (844) 467-2832
The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients.
Published on: June 07, 2013
Press release, December 3, 2012
